PPIs Increase Risk Of Stomach Cancer
Looks like there is yet another reason to rethink the long-term use of proton pump inhibitors. And this one is a doozy.
According to a new study, recently published in the BMJ journal, Gut, the long-term use of PPIs is linked to a more than doubling of the risk of developing stomach cancer.
And before you jump to the reasonable conclusion that these patients might have had untreated Helicobacter Pylori, this 2.4 fold increase in gastric cancer risk occurred in patients who had had H.pylori but had been successfully treated more than 12 months previously.
What’s more, the risk increased proportionally with the duration of PPI use and the dose, which the Hong ...